Fructose Malabsorption in Northern Norway (FINN)

University Hospital of North Norway

Status and phase: Completed; Phase 3; Phase 2

Conditions: Irritable Bowel Syndrome; Fructose Malabsorption

Treatments: Behavioral: diet restriction

Study type: Interventional

Funder types: Other

Identifiers

NCT00555191

N-136/2006(REK)

15567/NSD (Other Identifier)

Ref 1204 Biobankregisteret (Registry Identifier)

2006/136(REK-N) (Registry Identifier)

Details and patient eligibility

About

Different published studies has shown a possible co-variation between leakage of fructose to the great bowel and exacerbation of irritable bowel syndrome (IBS) symptoms.

The aim of the FINN trial is to study the role of fructose malabsorption in patients with IBS in order to evaluate different diagnostic criteria for fructose malabsorption and at the same time study the effect of diet treatment in this cohort of patients and estimate the prevalence of fructose malabsorption.

Enrollment: 182 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• IBS patients satisfying ROME 2 diagnostic criteria

Exclusion criteria

• Seriously ill
• Organic abdominal disease
• Other functional bowel disease

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

182 participants in 2 patient groups

1

Active Comparator group

Description:

PATIENTS IN THIS ARM IS INSTRUCTED IN FRUCTOSE REDUCED DIET FOR A PERIOD OF 3 MONTHS

Treatment:

Behavioral: diet restriction

2

No Intervention group

Description:

these patients use their usual diet